Crowley won't get a bid big enough to sell. He will not allow big pharma to steal the drug.
Like Iv'e been saying, FOLD will beat all estimates as JC is ready to move product. Buy the stock and watch the first year of sales be a bigger one that all analysts expect.
That's good despite the amount.
The sell for many reasons but they buy for just one...they think it's going higher.
First of all, they can short all they want. The company is gonna make us rich.
Second of all, you complain but give no suggestions as to what to do. And please don't start with the buy back stuff. It doesn't happen in these little biotechs.
Lastly, if you don't like the company then sell but don't come here and whine.
He will sell the living hell out of this drug once approved. Company is primed and ready to move it.
Sellers think they smart by selling news. Rookies will wish they hadn't exited.
I agree. Remember we had two things happen which changed the scene for FOLD. First was the FDA asking for more info. Yes this is not a good thing but often it just pushes back the timeline for approval which makes impatient investors sell and look for fast returns. Then shortly after we had the biotech bloodbath and while this may sound a bit crazy, FOLD has held up as good if not better than most of its peers during the selling.
If you held ths long, you might as well stay for the duration and for the EU decision. I know I am and expect good news.
FOLD tends to open higher most everyday, only to sell down within the next hour or two.
IMO, if we hold today's open, the stock is once again off to the races.
It's not Crowley, it's Feuerstein. He's the one who wrote last month that s decision was coming at that time. It's up to him to confirm info like that.
Maybe I'm wrong but I'm still not concerned and FOLD.
You buy stocks like FOLD for big risk and big moves. 50/50 for a biotech is a pretty decent bet. Sure it's even odds but most bios are way bigger long shots.